With Vuity Approval, AbbVie Continues Stepping Into Eye Care- AbbVie Could Create Market For Other Presbyopia Players Nov 3, 2021
Getting the Drop on Presbyopia: A look at the pharmacologic solutions in the treatment pipeline Sep 1, 2021
OIS Weekly: Company/Market Watch – Ocuphire Pharma Reports Positive Top-line Results in the MIRA-2 Phase III Registration Trial Mar 24, 2021